Introduction {#s001}
============

A [large proportion]{.smallcaps} of spinal cord injuries (SCI) are incomplete.^[@B1]^ SCI patients may also have preserved non-functional connections after clinically complete injuries.^[@B2]^ Strengthening residual pathways in incomplete SCI patients through a wide range of non-invasive methods has gained considerable attention in human SCI research.^[@B3],[@B4]^ Long-term potentiation (LTP), depending on the cooperativity and associativity of neuronal activation,^[@B5]^ has been one of the central targets in counteracting the connectivity weakness after neuronal trauma and disease. Indeed, evidence from animal studies indicates that stimulation protocols inducing spike-time-dependent--like plasticity between upper and lower motor neurons are promising tools for strengthening the residual connectivity and promoting motor recovery.^[@B6]^

Paired associative stimulation (PAS),^[@B9]^ a combination of transcranial magnetic stimulation (TMS) with peripheral nerve stimulation (PNS), is known to induce LTP-like plasticity in human motor^[@B10]^ and sensory^[@B11]^ tracts through synchronized activation of upper motor neurons and peripheral neurons in healthy individuals.^[@B12]^ PAS-induced plasticity is physiologically relevant, as it correlates with an increase in muscle voluntary force.^[@B13]^ Single-session PAS targeting the level of corticomotoneuronal synapses of the spinal cord induces transient plastic changes in healthy subjects and in incomplete SCI patients.^[@B14]^

The TMS-PNS combination is clinically advantageous as it is non-invasive and the required equipment is available in hospitals and research laboratories worldwide. Both stimulation modalities are safe and are in clinical use.^[@B15]^ PNS is used for improving muscle strength, increasing range of motion, reducing edema, and decreasing atrophy and pain.^[@B18]^ Various peripheral electrical stimulation techniques, such as transcutaneous electrical nerve stimulation (TENS), neuromuscular electrical stimulation (NMES), and functional electrical stimulation (FES) are widely used and are under intense investigation.^[@B18]^ Nevertheless, for SCI patients, only TENS has been identified as an effective treatment for reducing pain, with moderate strength of evidence.^[@B19]^ Little information is available on the therapeutic potential of PNS combined with TMS when applied over a long period of time. Thus far, only two reports describe the effects of long-term PAS in neurological patients.^[@B20],[@B21]^

A combination of different types of stimulation is increasingly used in animal and human research. It is essential to determine any possible clinically relevant advantages of paired versus unpaired stimulation.^[@B22]^ To our knowledge, no reports have compared long-term PAS with peripheral stimulation only.

The therapeutic potential of long-term PAS for SCI patients is unexplored. We have recently applied a PAS protocol with novel settings^[@B23]^ in a long-term way to two incomplete SCI patients,^[@B20]^ providing the first demonstration of the therapeutic potential of long-term PAS for this patient group.

Here we confirm these pilot results in a systematic study, and for the first time compare long-term PAS with long-term PNS.

Methods {#s002}
=======

Patients {#s003}
--------

The protocol ([Fig. 1](#f1){ref-type="fig"}) was approved by the Ethics Committee of Medicine of the Helsinki University Hospital. All patients provided informed written consent. Five patients (4 males; age 38--68, mean 48; [Table 1](#T1){ref-type="table"}) with incomplete chronic traumatic tetraplegia participated in the study. All patients fully adhered to the protocol. The individual conventional rehabilitation ([Table 1](#T1){ref-type="table"}) of all patients was continued in parallel with the study. The patients were asked to keep all exercises affecting the hands as symmetric as possible during the stimulation and follow-up periods. As part of conventional rehabilitation, Patient 5 received local peripheral stimulation to the wrists; this stimulation was on hold from 1 month before the study to the end of the follow-up period. The other patients did not receive any stimulation therapies. The medications affecting the central nervous system (CNS) are listed in [Table 1](#T1){ref-type="table"}. To ensure that any lack of vitamins or minerals would not be a constraint for a possible therapeutic effect, all patients were instructed to take a standard multivitamin dose during the stimulation and follow-up periods.

![Time line of the experiment and the summary of the stimulation protocol. MEP, motor-evoked potential; PAS, paired associative stimulation; PNS, peripheral nerve stimulation; SO, stimulator output; TMS, transcranial magnetic stimulation.](fig-1){#f1}

###### 

[Detailed Patient Information]{.smallcaps}

  *Patient*   *Gender*   *age*   *Neuro-logical level*   *AIS*   *Time since injury (years and months)*   *Height (cm)*   *Conventional rehabilitation (times per week)*                                               *Medication affecting CNS*
  ----------- ---------- ------- ----------------------- ------- ---------------------------------------- --------------- -------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------
  1           Male       38      C7                      B       4 y, 3 m                                 180             Physiotherapy (1 h × 2), occupational therapy (1 h × 2), swimming pool (1 h × 2)             Baclofen 25 mg × 3, clonazepam 1 mg × 3 (on demand up to 10 mg per day)
  2           Male       38      C7                      D       5 y, 10 m                                190             Physiotherapy (1 h × 2), occupational therapy (1 h × 1), swimming pool (1 h × 1)             Baclofen 25 mg × 2, clonazepam 0.5 mg × 1
  3           Male       42      C4                      C       6 y, 7 m                                 174             Physiotherapy (1-2 h × 1)                                                                    Pregabalin 75 mg + 225 mg, baclofen 25 mg × 2, tizanidine 6 mg × 2
  4           Male       53      C3                      C       3 y, 11 m                                174             Physiotherapy (1 h × 2), occupational therapy (1 h × 2), swimming pool (1 h × 1)             Mirtazapin 15 mg × 1, temazepam 5 mg × 1, clonazepam 1 mg × 2, baclofen 20 mg × 3
  5           Female     68      C5                      C       1 y                                      164             Physiotherapy (1 h × 1), swimming pool (1 h × 1), occupational therapy (1 h × 1) per month   Amitriptylline 25 mg × 1, gabapentin 300 mg + 900 mg + 900 mg, clonazepam 1 mg × 1

AIS, American Spinal Injury Association Impairment Scale; CNS, central nervous system.

Experimental setup {#s004}
------------------

Each patient received 16 sessions of stimulation during 4 weeks: 5 times per week during the first 2 weeks and 3 times per week thereafter ([Fig. 1](#f1){ref-type="fig"}), corresponding to the protocol that we used for our pilot patients.^[@B20]^ We hypothesized that the effect of PAS might be shorter at the beginning of the stimulation series than at its end, when the connections between upper and lower motor neurons have gained strength. Patient 5 went through an additional 3 sessions (5 weeks of stimulation); the longer period was considered useful because of the low baseline motor score and advanced age. We delivered PAS to one hand and sham TMS combined with real PNS to the other hand. The stimulated hand was selected randomly ([Table 2](#T2){ref-type="table"}). The stimulation order (PAS or PNS hand first) was changed at every session.

###### 

[Stimulation Parameters and Characteristics of PAS- and PNS-treated Hands]{.smallcaps}

  *Patient*   *Right- or left-handed*   *PAS hand*   *Motor score of PAS hand compared with PNS hand at first evaluation*   *PNS intensity for PAS hand (mA: med, uln, rad)*   *PNS intensity for PNS hand (mA: med, uln, rad)*   *ISI for PAS hand,(msec: med, uln, rad)*
  ----------- ------------------------- ------------ ---------------------------------------------------------------------- -------------------------------------------------- -------------------------------------------------- ------------------------------------------
  1           Right                     Left         Stronger by 39 points                                                  15, 15, 67                                         7, 9, 23                                           1, 3, 3
  2           Right                     Left         Weaker by 11 points                                                    4, 8, 18                                           16, 16, 21                                         5, 7, 6
  3           Left                      Right        Weaker by 44 points                                                    5, 8, 16                                           2, 7, 19                                           -8, −9, 2
  4           Right                     Right        Stronger by 6 points                                                   4, 26, 22                                          4, 16, 30                                          -6, −1, −2
  5           Right                     Right        Stronger by 9 points                                                   16, 16, 12                                         18, 18, 17                                         -1, 1, −1

ISI, interstimulus interval; med, median; PAS, paired associative stimulation; PNS, peripheral nerve stimulation; rad, radial; uln, ulnar.

Evaluation of the patients {#s005}
--------------------------

The patients, the physiotherapist evaluating motor and spasticity scores, and the clinical neurophysiologist evaluating F-responses were blinded to the treatment. Sensory scores were evaluated by an unblinded physician.

Motor scores {#s006}
------------

An experienced physiotherapist performed manual motor testing^[@B24]^ ([Supplementary Table 1](#SD1){ref-type="supplementary-material"}; see online supplementary material at <http://www.liebertpub.com>) of each muscle with other muscles manually immobilized. The first evaluation was done before, the second immediately after, and the third 1 month after the 4-week intervention ([Fig. 1](#f1){ref-type="fig"}). We calculated the differences between the first and second evaluation (change during 4-week stimulation), the second and third evaluation (change during the follow-up period), and the first and third evaluation (total change) for each muscle. The differences were averaged for the PAS and PNS hand of each patient, and the PAS-to-PNS ratio was counted from the averages ([Supplementary Table 1](#SD1){ref-type="supplementary-material"}).

The physiotherapist did not have access to the results of the previous evaluations. The muscles with a value of 5 before intervention (full strength) were not included in the analysis of the therapeutic effects. In addition, the muscles of the right thumb of Patient 3 were excluded from the analysis, because the thumb ligaments were injured before SCI. The full list of muscles evaluated in each patient is provided in [Table 3](#T3){ref-type="table"}.

###### 

[List of Evaluated Muscles]{.smallcaps}

  ---------------------------------------------
  **Upper limb**
  Pronator teres and quadratus
  Flexor carpi radialis
  Flexor digitorum superficialis
  Flexor digitorum profundus (fingers II-III)
  Flexor pollicis brevis
  Flexor pollicis longus
  Opponens pollicis
  Abductor pollicis brevis
  Adductor pollicis
  Dorsal interossei
  Abductor digiti minimi
  Palmar interossei
  Flexor digitorum profundus (fingers iv-v)
  Flexor carpi ulnaris
  Extensor digitorum
  Abductor pollicis longus
  Extensor pollicis longus
  Extensor pollicis brevis
  Extensor carpi radialis
  Extensor carpi ulnaris
  Brachioradialis
  Supinator and biceps brachii (supination)
  Triceps brachii
  Serratus anterior
  Upper trapezius and levator scapulae
  Anterior deltoideus and supraspinatus
  Middle deltoideus and supraspinatus
  Posterior deltoideus
  Infraspinatus and teres minor
  Biceps and brachialis
  Lower trapezius
  Middle trapezius and rhomboids
  Rhomboids
  **Neck and body**
  Neck extensors
  Neck flexors
  Sternocleidomastoideus
  Erector trunci
  Quadratus lumborum
  Rectus abdominis
  External and internal oblique
  **Lower limb**
  Iliopsoas
  Gluteus maximus
  Gluteus medius
  Adductors (hip)
  External rotators (hip)
  Internal rotators (hip)
  Semitendinosus
  Biceps femoris
  Quadriceps femoris
  Gastrocnemius and soleus
  Tibialis anterior
  Tibialis posterior
  Peroneus longus and brevis
  Lumbricales and flexor hallucis brevis
  Flexor hallucis longus
  Flexor digitorum longus and brevis
  Extensor digitorum longus and brevis
  Extensor hallucis longus
  ---------------------------------------------

Spasticity {#s007}
----------

An experienced physiotherapist evaluated spasticity by a modified Asworth Scale from elbow (extensors, flexors), wrist (extensors, flexors), hip (flexors, extensors, adductors), knee (flexors, extensors), and ankle (plantar flexors) joints.

Motor evoked potentials (MEPs) were measured to the stimulation of each hemisphere, but the amplitudes and latencies could not be reliably evaluated due to background spasticity. In four patients, we analyzed the number of spasticity-related spikes from the electromyography (EMG) derived from MEP recordings. For each patient, 500-msec spontaneous EMG periods recorded immediately before the 15 TMS pulses, delivered with 3.3-sec intervals (altogether 7.5 sec) were analyzed: from abductor pollicis brevis (APB), abductor digiti minimi (ADM), and brachioradialis (BR). The number of motor unit potentials exceeding the baseline EMG was calculated manually from the recordings. We ensured that the baseline was equal in all recordings.

Transcranial magnetic stimulation (TMS) {#s008}
---------------------------------------

We administered TMS with an eXimia magnetic stimulator (Nexstim Ltd., Helsinki, Finland) with a figure-of-eight coil. The device incorporates a magnetic resonance imaging (MRI)-based navigation system. Optimal stimulation sites for APB, ADM, and BR were defined by mapping the primary motor cortex. Spasticity-related EMG activity and movement artifacts resulting from the activation of off-target muscles with better-preserved innervation during mapping prevented an exact resting motor threshold (RMT) determination. Each patient was mapped at a wide range of stimulator output (SO) intensities; in muscles with an RMT over 100% SO we used muscle pre-activation, motor imagery, or both to elicit MEPs. High TMS intensities elicited MEPs from the muscles of interest more effectively, whereas at lower intensities, there were less movement artifacts. "Hot spots" were determined as sites where MEPs were most consistently elicited at a wide range of intensities. For MEP latency determination, 15 TMS pulses were administered over the selected hot spot of each muscle. Sham TMS was performed with identical stimulation parameters by placing a 15-cm plastic separating block between the TMS coil and the patient\'s head.

Peripheral nerve stimulation (PNS) {#s009}
----------------------------------

PNS was given with a Dantec Keypoint^®^ electroneuromyography device (Natus Medical Inc., Pleasanton, CA) using surface electrodes (Neuroline 720; Ambu A/S, Ballerup, Denmark). We stimulated the median and ulnar nerves at the wrist, and radial nerve at the arm. For the photographs of the stimulation sites, please see the study by Shulga and colleagues.^[@B20]^ In radial nerve stimulation, the electrodes were manually pressed against the tissues to decrease the distance between the electrodes and the nerve; adequate stimulation was verified by observing the activation of the muscles innervated by the stimulated nerve. Stimulation intensity was individually adjusted for each nerve of each patient, and set to the minimum value reliably evoking the F-responses measured with single 1-msec pulses (see below). This was done to reliably ensure the activation of the motor fibers^[@B23]^ ([Table 2](#T2){ref-type="table"}). PNS was administered in 50-Hz trains consisting of 6 biphasic 1-msec square wave pulses (that is, each train consisted of one pulse every 20 msec during 100 msec).^[@B20]^ In all patients, the stimulation elicited visible contractions of the muscles innervated by the stimulated nerves. All patients with well-preserved sensation (Patients 1--3 and 5) perceived PNS as unpleasant, especially during the first sessions. However, all patients quickly adapted to stimulation and tolerated it in subsequent sessions. Local skin anesthesia with EMLA^[@B23]^ ointment prior to stimulation was offered to patients; none of them wanted the anesthesia. No patients experienced autonomic dysreflexia symptoms during the stimulation.

F-response measurements {#s010}
-----------------------

F-wave latencies, amplitudes, and persistence were determined from 10 F-responses recorded with the Dantec Keypoint^®^ device (see above) using surface electrodes (Neuroline 720; Ambu A/S, Ballerup, Denmark). In stimulation we used 0.2-msec pulses at supramaximal intensity (i.e., increasing the intensity did not produce an additional increase in F-wave amplitude). The stimulating electrodes were placed as for PNS (see above). The recording electrodes were placed on APB for the median nerve, on ADM for the ulnar nerve, and on BR for the radial nerve. Thereafter, to individually select PNS intensity for each patient, we determined the minimal intensity eliciting detectable F-responses using single 1-msec pulses. During the measurements the temperature of the limb was \>30°C.

PAS/PNS-only sessions {#s011}
---------------------

TMS and PNS were triggered by Presentation (Neurobehavioral Systems Inc., Albany, NY) software. PAS was given at 0.2 Hz. The interstimulus interval (ISI) between TMS and PNS was determined individually for each patient on the basis of F-response and MEP latencies as described previously.^[@B20],[@B23],[@B25]^ We aimed at ISI = 0 msec, that is, simultaneous arrival of TMS-evoked activation and the activation evoked by the first pulse of PNS train at the level of the corticospinal synapses of the cervical spinal cord. During PAS, we applied TMS at 100% SO, eliciting the highest possible amount of orthodromic volleys by a single TMS pulse.^[@B23]^ High-intensity TMS pulses result in a high-frequency repetitive discharge of corticospinal neurons and this ensures multiple collisions of pre- and post-synaptic pulses at the spinal cord level.^[@B26]^ For sham TMS, we used 100% SO to ensure a similar noise level. Each 20-min PAS or PNS-only session comprised 240 PAS pulses or 240 PNS-only trains. During both PAS and PNS sessions, the patients were instructed to concentrate on the movement produced by the muscles innervated by the stimulated nerve. We hypothesized that motor imagery during PAS sessions lowers the RMT of the corresponding cortical representation area and thus increases the number of corticospinal volleys elicited by each TMS pulse. Each experimental session took 2 h (PAS hand: 20 min × 3 nerves and PNS hand: 20 min × 3 nerves), excluding the time for preparation.

Statistical analysis {#s012}
--------------------

Data are presented as mean ± standard error. Statistical significance was assessed by Wilcoxon signed rank tests with IBM SPSS Statistics 22 software.

Results {#s013}
=======

Motor scores {#s014}
------------

Individual hand motor score results are provided in [Supplementary Table 1](#SD1){ref-type="supplementary-material"} (see online supplementary material at <http://www.liebertpub.com>). Immediately after the intervention, the motor scores of both hands increased significantly. The PAS hand improved by 0.74 ± 0.18 points (*p* \< 0.0001, *n* = 100 muscles from 5 patients), whereas the PNS hand improved by 0.55 ± 0.08 points (*p* \< 0.0001, *n* = 107 muscles from 5 patients). There was no significant difference between the improvement in PAS and PNS hands (PAS/PNS: 142 ± 41%, *p* = 0.5, *n* = 5 patients). During follow-up, however, the PAS hand significantly improved further by 0.37 ± 0.08 points (*p* = 0.007, *n* = 100 muscles from 5 patients), whereas there was no significant increase in the motor score in the PNS hand (0.11 ± 0.08, *p* = 0.55, *n* = 107 muscles from 5 patients). The improvement during follow-up was significantly higher in the PAS hand ([Fig. 2](#f2){ref-type="fig"}, PAS/PNS: 228 ± 28%, *p* = 0.042, *n* = 5 patients). At the third evaluation, the total improvement (third vs. first evaluation) was significantly higher in the PAS than in the PNS hand ([Fig. 2](#f2){ref-type="fig"}, 176 ± 29%, *p* = 0.046, *n* = 5 patients). Total improvement (third vs. first evaluation) in the PAS hand was 1.02 ± 0.17 points (*p* \< 0.0001, *n* = 100 muscles from 5 patients) and in the PNS hand 0.65 ± 0.14 points (*p* \< 0.0001, *n* = 107 muscles from 5 patients). The motor scores of neck, body, and leg muscles did not significantly improve either at the PAS or at the PNS side ([Supplementary Table 2](#SD2){ref-type="supplementary-material"}; see online supplementary material at <http://www.liebertpub.com>).

![Improvement in the PAS-treated and PNS-treated hand during stimulation (second vs. first evaluation), follow-up period (third vs. second evaluation), and in total (third vs. first evaluation). PAS, paired associative stimulation; PNS, peripheral nerve stimulation.](fig-2){#f2}

Sensory scores {#s015}
--------------

We used the standard scale of American Spinal Injury Association Impairment Scale (AIS) examination to test C2--T10 sensation levels before and immediately after the intervention. The sum of the score was calculated for each patient. Neither PAS (difference of sums after minus before intervention: light touch −0.8 ± 1 points, *p* = 0.46 and pin-prick score 3 ± 1.8 points, *p* = 0.14, *n* = 5 patients) nor PNS (light touch 1.2 ± 0.6 points, *p* = 0.1 and pin-prick score −1.4 ± 2 points, *p* = 0.7, *n* = 5 patients) had an effect on sensory scores.

Spasticity {#s016}
----------

### Modified Asworth Scale {#s017}

Spasticity was assessed before, immediately after, and 1 month after the intervention. The difference in points for each joint was calculated similarly to the motor score evaluation. There was no effect of PAS or PNS ([Supplementary Table 3](#SD3){ref-type="supplementary-material"}; see online supplementary material at <http://www.liebertpub.com>).

### EMG {#s018}

The number of spasticity-related spikes above the EMG baseline from APB, ADM, and BR muscles did not change significantly by the intervention. The number of spasticity-related spikes after the intervention decreased by 33 ± 35 spikes in the PAS hand (*p* = 0.24, n = 12 measurements) and by 23 ± 16 spikes in the PNS hand (*p* = 0.4, n = 12 measurements).

F-responses {#s019}
-----------

We analyzed minimum and maximum F latencies (F min, F max), F amplitudes, and F persistence (pulses that generated F-responses, % of total amount) from ulnar and median nerves of every patient before and immediately after the intervention. PAS or PNS did not affect these parameters. The average change of median and ulnar nerve measurements by the intervention (*n* = 10 measurements from 5 patients) was F min PAS −0.14 ± 0.8 msec, *p* = 0.44 and PNS 0.44 ± 0.78 msec, *p* = 0.86, F max PAS −0.97 ± 1.5 msec, *p* = 0.8 and PNS −0.39 ± 0.6 msec, *p* = 0.33, F amplitudes PAS 0.18 ± 0.1 mV, *p* = 0.16 and PNS 0.07 ± 0.07 mV, *p* = 0.1, F persistence PAS 1 ± 5%, *p* = 0.5, and PNS −3 ± 3%, *p* = 0.32.

Neuropathic pain {#s020}
----------------

Patients 2, 3, and 4 reported no neuropathic pain before or after the intervention. Patient 1 reported constant unpleasant tingling in both arms and feet; the tingling was absent after the intervention. Patient 5 reported bilateral constant pain between the elbows and wrists (1 h daily, visual analog scale \[VAS\] 3) before the intervention. After the intervention, she experienced approximately similar pain (1 h daily VAS 4--5). This increase was probably due to interruption of local peripheral stimulation to the wrists (see [Methods](#s002){ref-type="sec"}). After the follow-up period the local peripheral stimulation was resumed, and the intensity of pain returned to VAS 3.

Autonomic functions {#s021}
-------------------

There were no effects on autonomic functions.

Adverse effects {#s022}
---------------

Patients 1 and 2 reported that it was difficult to sit in the same position during the 2-h session. The seating was improved and Patients 3--5 reported no such problems.

Discussion {#s023}
==========

The effect of long-term PAS on the hand motor output in 5 chronic tetraplegic patients was therapeutic. After 4 weeks of stimulation and 1-month follow-up, each deficient muscle in the PAS-treated hand improved on average by 1 point on a 0--5 scale. Long-term PAS was more effective than long-term PNS. This is the first sham-controlled study on long-term PAS in SCI patients, and first direct comparison of long-term PAS with long-term unpaired peripheral stimulation in any neurological patient group.

The observed therapeutic effect was not due to alleviation of spasticity. The unchanged F-response parameters indicate that the effect was also not due to changes in peripheral nerves. The most dramatic difference between the PAS- and PNS-treated hands occurred during the follow-up period, when the PAS hand continued to improve, whereas the PNS hand did not. PAS is thought to induce LTP-like plasticity at the targeted synapses.^[@B9]^ Evidence derived from *in vitro* studies and animal experiments indicates that correlated pre-and post-synaptic spiking releases neurotrophins that can contribute to structural changes enhancing the transmission between pre- and post-synaptic neurons. Formation of new synapses, growth of new dendritic spines, and cytoskeletal reorganization can be induced by neurotrophins. These changes are sometimes referred as being part of the "late LTP" and require long-term activation.^[@B27],[@B28]^ The plausible mechanism of long-term PAS action is the structural reorganization at the corticomotoneuronal synapses of the cervical spinal cord. The innervation strengthened by PAS possibly enabled the hands to improve beyond the stimulation period as a result from increased voluntary activity and possibly also by trophic support to muscles.^[@B29]^ Further research, however, is needed to elucidate to which extent the cortical versus spinal mechanisms are involved in the recovery process.

PNS induced contractions of the muscles innervated by the stimulated nerve. It is plausible that PNS-induced improvement was due to training of the muscles, which was absent after the stimulation was discontinued. This is consistent with our recent observation in healthy subjects, where a PAS protocol identical to the one used here enhanced MEPs, whereas PNS did not.^[@B23]^ The therapeutic effect of PAS presumably comprises both muscle training by the PNS component and the strengthening of neural connections. It remains to be determined whether the difference between PAS and PNS-treated hands would be greater if the stimulation lasted longer than 4 weeks.

In our pilot study,^[@B20]^ we administered PNS-only to one nerve of one patient and did not observe the effect of the PNS. Here, PNS was given to three nerves and produced a statistically significant effect at the group level. It is noteworthy that although various peripheral stimulation techniques are widely used in rehabilitation after SCI, the settings of PNS we used here are not in routine clinical use. The potential of this protocol in rehabilitation could be of clinical interest by itself in patients having contraindications to TMS.

We cannot rule out the effect of TMS on the contralateral hemisphere.^[@B30]^ Nevertheless, because the hands were not stimulated simultaneously but in sequential order, there is no possibility that the PNS hand would have received any external paired stimuli. Similarly to PAS, we also combined PNS with motor imagery to isolate the effect of TMS. Therefore, at the PNS side some motor cortex activation also occurred simultaneously with the electrical stimulation, although it was clearly different from TMS. The motor areas of both hemispheres interact in healthy individuals and in stroke patients.^[@B31]^ Accordingly, it is not known whether the improvement of the PAS hand could have contributed to the improvement of the PNS hand. It remains to be determined whether improvement in one hand by PAS would lead to improvement in the other hand if the other hand was untreated. Comparing the hands of the same patient is advantageous as it circumvents the heterogeneity of SCI patients. Both hands of a single patient are also under the influence of identical medication, genetic factors, duration since injury, type of injury, and other patient-specific traits. Importantly, the superiority of the outcome in the PAS versus PNS hand was observed in all patients, regardless of whether the PAS hand was dominant or non-dominant ([Table 2](#T2){ref-type="table"}), and regardless of whether the PAS hand was weaker or stronger at the initial evaluation ([Table 2](#T2){ref-type="table"} and [Supplementary Table 1](#SD1){ref-type="supplementary-material"}; see online supplementary material at <http://www.liebertpub.com>).

The treatment did not induce adverse effects. All patients tolerated the intervention well and were motivated to fully adhere to the protocol. The age range of the patients extended up to 68 years, which is important as incidence of SCI in the older population is increasing.^[@B32]^

The benefit of the treatment was not only objectively determined by our measurements, but also perceived by the patients. All 5 patients reported that their hand movements improved already before the test results. Functional improvements of daily activities were reported as well. Patients with high baseline motor score before the treatment achieved more functional benefit than the ones with lower scores. For example, Patient 1 became able to open bottles and Patient 3 became able to open doors with the PAS-treated hand. These regained skills remained during the follow-up period. The patient with the lowest baseline score did not achieve functional benefits; nevertheless, she was satisfied with the improved ability to move the hands. Four weeks is, however, most probably too short a period to unveil the full potential of the method to induce functional improvements. We propose that the long-term PAS protocol presented here is a useful tool for rehabilitation of SCI. Its properties and therapeutic potential should be investigated in a larger cohort of different types of SCI patients, using longer periods of stimulation, and starting early after SCI.

Supplementary Material
======================

###### Supplemental data

###### Supplemental data

###### Supplemental data

Acknowledgments {#s024}
===============

We are deeply grateful to our patients for participating in the study. We thank David Montero-Danger for excellent technical assistance (MRI) and Andrey Rodionov for cross-checking the data. The research was supported in part by the Finnish Cultural Foundation (AT and AS), the Maire Taponen Foundation (AS), the Helsinki University Hospital governmental subsidiary funds for clinical research (AS), the Emil Aaltonen Foundation (AS), and the Faculty of Medicine, University of Helsinki (AS).

Author Disclosure Statement {#s025}
===========================

PL reports personal fees from Nexstim Ltd. outside the submitted work. Other authors have nothing to report; no competing financial interests exist.
